FDA Recall Open, Classified

Phothera 200, Phototherapy Devices indicated for use to treat diagnosed skin disorders such as, but not limited to, Psoriasis, Vitiligo, and Atopic Dermatitis (Eczema) under the direction of a physician, Model Numbers 210NDT4 and 210NCL4

Recall: Z-2295-2026 · Initiated December 10, 2025

Recall

Recall Number
Z-2295-2026
Event Number
98817
Firm
Daavlin Distributing Company
FEI Number
1526255
Product Code
FTC
Status
Open, Classified
Root Cause
Labeling Change Control
Initiated
December 10, 2025
Posted
June 2, 2026
Address
205 W Bement St, Bryan, OH, 43506-1264

Description

Phothera 200, Phototherapy Devices indicated for use to treat diagnosed skin disorders such as, but not limited to, Psoriasis, Vitiligo, and Atopic Dermatitis (Eczema) under the direction of a physician, Model Numbers 210NDT4 and 210NCL4

Reason

Some of the Calibration/Output Certificates had the outputs reversed.

Action

An URGENT: MEDICAL DEVICE ADVISORY NOTICE dated 12/11/25 was sent to customers. Dual calibration allows you to treat at the surface (0 ) of the device or at 9 inches (9 ) away. It has come to our attention that some of the Calibration/Output Certificates had the outputs reversed. Actions to be taken by the Customer/User: Talk to your physician regarding treatment plans with the new information listed below. If you have any questions or concerns, please do not hesitate to contact our office at (800) 322-8546. Monday through Friday, 8:00 AM to 4:30 PM, Eastern Time. Thank you for your cooperation.

Distribution

US Nationwide distribution.

Quantity

368 units